Zobrazeno 1 - 3
of 3
pro vyhledávání: '"CD271 enrichment"'
Autor:
Sylvia Müller, Lyndsey Nicholson, Naif Al Harbi, Elena Mancuso, Elena Jones, Anne Dickinson, Xiao Nong Wang, Kenneth Dalgarno
Publikováno v:
BMC Biomedical Engineering, Vol 1, Iss 1, Pp 1-10 (2019)
Abstract Background Mesenchymal stromal cells (MSCs) are widely used in clinical trials for bone repair and regeneration. Despite previous evidence showing a prominent osteogenic potential of 2D cultured CD271 enriched MSCs, the osteogenic potential
Externí odkaz:
https://doaj.org/article/f23abfeedcbe46c19f645e3dd1df67ea
Autor:
L Nicholson, Xiao-Nong Wang, Elena Mancuso, Sylvia Müller, Kenneth Dalgarno, Naif Al Harbi, Elena Jones, Anne M. Dickinson
Publikováno v:
BMC biomedical engineering
BMC Biomedical Engineering, Vol 1, Iss 1, Pp 1-10 (2019)
BMC Biomedical Engineering, Vol 1, Iss 1, Pp 1-10 (2019)
Background Mesenchymal stromal cells (MSCs) are widely used in clinical trials for bone repair and regeneration. Despite previous evidence showing a prominent osteogenic potential of 2D cultured CD271 enriched MSCs, the osteogenic potential of CD271
Autor:
Müller S; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Nicholson L; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Al Harbi N; School of Engineering, Newcastle University, Newcastle upon Tyne NE2 4HH, UK., Mancuso E; School of Engineering, Newcastle University, Newcastle upon Tyne NE2 4HH, UK., Jones E; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK., Dickinson A; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Wang XN; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK., Dalgarno K; School of Engineering, Newcastle University, Newcastle upon Tyne NE2 4HH, UK.
Publikováno v:
BMC biomedical engineering [BMC Biomed Eng] 2019 Jun 19; Vol. 1, pp. 16.